Kajeno Bill & Melinda Gates Foundation le Wellcome ba tšepisitse e mong le e mong oa bona $150 milione bakeng sa kakaretso ea lidolara tse limilione tse 300 ho Coalition for Epidemic Preparedness Innovations (CEPI), tšebelisano ea lefats'e e qalileng lilemo tse hlano tse fetileng bekeng ena ke mebuso ea Norway le India, Gates Foundation, Wellcome, le Seboka sa Moruo oa Lefatše. Litšepiso tsena li tla pele ho kopano ea lefats'e ka bophara ka Hlakubele ho ts'ehetsa leano la ponelopele la CEPI la lilemo tse hlano la ho itokisetsa hantle, ho thibela le ho arabela ka ho lekana ho mafu a seoa le mafu a seoa a tlang.

Ho tloha ha e qala, CEPI e phethile karolo ea mantlha ea mahlale ho lokiseng mafu a seoa lefatšeng ka bophara, ho okamela likhatelopele tse ngata tsa mahlale le ho beha boitokisetso ba seoa bohareng ba lenaneo la lefats'e la bophelo bo botle la R&D. Ha seoa sa COVID-19 se qala, CEPI e ile ea arabela hang-hang, ea haha e 'ngoe ea li-portfolio tse kholo ka ho fetisisa le tse fapaneng ka ho fetisisa lefatšeng tsa bakuli ba ente ea COVID-19 - ba 14 ka kakaretso, ho kenyeletsoa ba tšeletseng ba bona ba ntseng ba tsoela pele ho fumana chelete, 'me ba bararo ba bona ba fuoe maemo a tšohanyetso. sebelisa lethathamo la Mokhatlo oa Lefatše oa Bophelo (WHO).

CEPI e entse matsete a pele ho nts'etsopele ea ente ea Oxford-AstraZeneca COVID-19, e seng e pholosa bophelo lefatšeng ka bophara. Khoeling e fetileng, ente ea Novavax e thehiloeng ho protheine ea COVID-19 - e tšehelitsoeng haholo ke CEPI - e amohetse lethathamo la ts'ebeliso ea tšohanyetso ea WHO mme e ikemiselitse ho thusa boiteko ba ho laola seoa sena lefatšeng ka bophara. Litekanyetso tse fetang bilione tsa ente ea Novavax li se li fumaneha ho COVAX, morero oa lefats'e o etelletsoeng pele ke CEPI o ikemiselitseng ho fana ka phihlello e lekanang ea liente tsa COVID-1. CEPI e boetse e ntse e tsoela pele ho sebetsa molokong o latelang oa liente tsa COVID-19, ho kenyeletsoa liente tsa "variant-proof" tsa COVID-19 le lithunya tse ka sireletsang khahlano le li-coronavirus tsohle, tse ka tlosang tšokelo ea mafu a seoa a nakong e tlang.

Ka ntle ho COVID-19, CEPI e tlatsitse lekhalo la bohlokoa ho ts'ehetsa tekano ea ente hammoho le R&D. CEPI hajoale e ts'ehetsa lipatlisiso le nts'etsopele ea liente tse fumanehang khahlano le mafu a mang a tšoaetsanoang, ho kenyeletsoa liente tsa pele tsa ho fihlela liteko tsa tleliniki khahlano le livaerase tse bolaeang tsa Nipah le Lassa. Mokhatlo o boetse o phethile karolo ea bohlokoa boitekong ba ho felisa Ebola, ho kenyelletsa le ho tšehetsa nts'etsopele ea ente ea bobeli ea Ebola ka Janssen. Ntle le ho nts'etsapele nts'etsopele ea ente e thehiloeng mahlaleng le lipolanete tse ncha tsa ente, CEPI e tsepamisitse maikutlo ho fokotseng haholo nako eo e e nkang ho etsa liente tse pholosang bophelo khahlano le ts'okelo efe kapa efe e ncha ea vaerase (e bitsoang "Boloetse X") - pele matsatsi a 100 a tsoa. ho latelana. Sena se emela motsoako oa sekala le lebelo le ka pholosang maphelo a limilione le libilione tsa lidolara.

Boloetse bona bo se bo eketsehile ka maqhubu ho pota lefatše, bo totobatsa karolo ea bohlokoa ea mekhatlo ea machaba e kang CEPI e behileng phihlello e lekanang motheong oa thomo ea bona. Lintlha tsa morao-rao tse tsoang Univesithing ea Leboea-bochabela li bonts'a hore ho ba teng ha liente linaheng tse nang le meputso e tlase joalo ka Kenya ho ne ho tšoana le linaheng tse nang le chelete e ngata joalo ka UK kapa US, liperesente tse 70 tsa batho ba shoang COVID-19 ho fihlela joale li ka be li ile tsa qojoa.

United Kingdom e tla tšoara kopano ea ntlafatso ea CEPI ka la 8 Hlakubele 2022, London. Ketsahalo ea ho bokella chelete e tla kopanya mebuso, li-philanthropists, le bafani ba bang ho ts'ehetsa leano la CEPI la lilemo tse hlano la ho sebetsana le kotsi ea mafu a seoa le mafu a seoa, tse ka thibelang lefu la limilione le libilione tsa lidolara tšenyong ea moruo.

SEO U LOKELANG HO SE NKA HO SEHLOOHO ENA:

When the COVID-19 pandemic began, CEPI responded immediately, building one of the world’s largest and most diverse portfolios of COVID-19 vaccine candidates—14 in all, including six of which continue to receive funding, and three of which have been granted emergency use listing by the World Health Organization (WHO).
In addition to advancing the science underlying vaccine development and new vaccine platforms, CEPI is focused on dramatically reducing the time it takes to develop lifesaving vaccines against any new viral threat (referred to as “Disease X”)—to within 100 days of a pathogen being sequenced.
Since its inception, CEPI has played a central scientific role in curbing epidemics around the world, overseeing a number of scientific breakthroughs and putting pandemic preparedness at the center of the global health R&D agenda.